secwatch.observer — SEC 8-K summary
======================================

Issuer:     Outset Medical, Inc. (OM)
CIK:        0001484612
Form:       8-K
Filed at:   2025-02-19T23:59:59+00:00
Accession:  0000950170-25-023167
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Outset Medical Q4 revenue $29.5M, beats guidance; 2025 outlook $115-125M revenue, high-30% gross margin
--------------------------------------------------------------------------------

- Q4 revenue $29.5M (+3% QoQ, -3% YoY); full-year $113.7M, beating prior guidance.
- Q4 GAAP gross margin 36.5% (37.7% non-GAAP), up 11pp YoY; recurring revenue up 21% to $83.9M in 2024.
- Q4 net loss $25.6M ($0.49/sh) vs $38.6M ($0.77/sh) YoY; non-GAAP loss $19.3M ($0.37/sh).
- Tablo installed base ~6,000 consoles (+10% in 2024); cash $162M at yr-end, ~$210M after Jan 2025 financing.
- 2025 guidance: revenue $115-125M, non-GAAP gross margin high-30% range; cash burn <$50M vs $103M in 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1484612/000095017025023167/0000950170-25-023167-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1484612/000095017025023167/om-20250219.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-023167

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer